You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

SODIUM ACETATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for SODIUM ACETATE
Drug Prices for SODIUM ACETATE

See drug prices for SODIUM ACETATE

Pharmacology for SODIUM ACETATE

US Patents and Regulatory Information for SODIUM ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Milla Pharms SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 214805-004 Jan 22, 2024 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Fresenius Kabi Usa SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 206687-001 Oct 30, 2017 AP RX No Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Hikma SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 216920-001 Mar 15, 2024 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Somerset Theraps Llc SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 219826-002 Sep 18, 2025 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Milla Pharms SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 214805-001 May 4, 2021 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Milla Pharms SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 214805-003 May 4, 2021 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Hospira SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 018893-003 Sep 2, 2014 AP RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Sodium Acetate

Last updated: July 27, 2025

Introduction

Sodium acetate, a chemical compound with the formula CH₃COONa, is widely utilized across multiple sectors, including pharmaceuticals, food processing, textiles, and industrial applications. In the pharmaceutical domain, sodium acetate is primarily employed as a buffering agent, electrolyte replenisher, and in the manufacturing of medicinal formulations. Its stability, safety profile, and cost-effectiveness render it a vital ingredient in various drug formulations and clinical solutions. Understanding the evolving market landscape and financial trajectory of sodium acetate is essential for stakeholders—including manufacturers, investors, and health authorities—to navigate future opportunities and challenges.

Market Overview

The global sodium acetate market is driven by its inherent versatility in multiple end-user industries. As per industry reports, the pharmaceutical sector stands as a significant contributor, owing to increasing demand for electrolyte solutions and buffering agents in hospitals, clinics, and surgical centers. The escalating prevalence of chronic diseases, such as diabetes and cardiovascular conditions, necessitates extensive use of electrolyte management, bolstering demand for sodium acetate-based formulations [1].

According to Allied Market Research, the global sodium acetate market was valued at approximately USD 600 million in 2021, with an anticipated compound annual growth rate (CAGR) of around 4% over the next five years. The growth is largely fueled by expanding pharmaceutical manufacturing and regulatory approvals for electrolyte and infusion solutions. Further, the rising demand from the food industry—where sodium acetate functions as a preservative and flavoring agent—adds to the overall market momentum [2].

Key Market Drivers

1. Rising Demand in Pharmaceuticals

The healthcare industry’s need for stable, safe, and cost-efficient buffering agents underpins the demand for sodium acetate. It features prominently in intravenous fluid formulations, including parenteral nutrition and electrolyte replenishment solutions, benefiting from its non-toxic nature and suitability for various patient demographics. The increasing adoption of sodium acetate in hospitals globally correlates with the rising burden of dehydration and electrolyte imbalance cases [3].

2. Expansion in Food and Beverage Industry

Sodium acetate is extensively utilized as a food additive, designated as E262 in the European Union. Its roles include pH regulation, preservative, and mold inhibitor. The global food processing sector's expansion, especially in emerging economies, bolsters sales of sodium acetate to major food manufacturers seeking effective preservative solutions compliant with safety standards [4].

3. Growing Industrial and Textile Applications

Beyond pharmaceuticals and food, sodium acetate’s use in textile dyeing and industrial processes continues to grow, particularly in China and India. Its effectiveness as a dispersing agent and pH stabilizer supports manufacturing efficiency and environmental compliance, sustaining steady demand.

4. Regulatory Framework and Safety Standards

Regulatory approvals by entities such as the U.S. Food and Drug Administration (FDA), European Food Safety Authority (EFSA), and WHO classifications affirm sodium acetate's safety and expand its utilization scope. Stricter safety standards promote consistent quality, attracting more pharmaceutical and food industry clients [5].

Market Challenges

Despite robust growth prospects, several challenges impact the sodium acetate market:

  • Price Volatility of Raw Materials: The primary raw material, acetic acid, is subject to fluctuations driven by oil and natural gas prices, impacting sodium acetate production costs.
  • Environmental Regulations: Stricter environmental policies on chemical manufacturing emissions necessitate investment in cleaner production technologies, potentially increasing operational costs.
  • Competition from Alternative Buffering Agents: Agents such as citrate and phosphate buffers offer alternative options, potentially reducing sodium acetate's market penetration in certain applications.

Competitive Landscape

The market comprises several key players, including:

  • Tosoh Corporation
  • Fosfa Group
  • Sigma-Aldrich (a wholly owned subsidiary of Merck KGaA)
  • Sachem Inc.
  • Shandong Zibo Qixiang Industry Co., Ltd.

These companies focus on product quality, cost efficiency, and expansion into emerging markets to widen their market share. Strategic partnerships, capacity expansions, and R&D investments are prominent as firms aim to capitalize on growing demand.

Future Financial Trajectory

The projection for sodium acetate’s financial performance hinges on several factors:

Market Growth and Revenue Projections

With an estimated CAGR of 4%, the market is poised for steady expansion. Extrapolating from 2021 valuations, revenues could reach approximately USD 740 million by 2026, contingent upon sustained demand in pharmaceuticals and food sectors [1][2].

Pricing Dynamics

Market prices are expected to remain relatively stable but sensitive to raw material costs and regulatory changes. Raw material procurement efficiencies and technological innovations in manufacturing could mitigate profit margin pressures.

Investment Opportunities

New manufacturing facilities focused on environmentally friendly processes and higher-grade pharmaceutical applications could yield premium pricing and enhanced profitability. Emerging markets in Asia-Pacific are particularly attractive due to expanding healthcare infrastructure and food processing industries.

Potential Impact of Innovations

Advances in synthetic biology and green chemistry practices could reduce production costs and environmental impact. Additionally, alternative buffer systems compete with sodium acetate, but given its proven safety profile, market displacement is unlikely absent technological breakthroughs.

Regulatory and Market Outlook

The evolving regulatory landscape favors sodium acetate’s secure profile; however, adherence to environmental and quality standards remains critical. International trade agreements and tariffs could influence pricing, supply chain logistics, and market access, particularly for exports from Asia to North America and Europe.

Key Market Segments and Applications

  • Pharmaceuticals: Intravenous solutions, electrolyte replenishment, dialysis fluids.
  • Food Industry: Preservatives, flavor enhancers, pH regulators.
  • Industrial Use: Textile dyeing, printing, and dispersants.

Conclusion

Sodium acetate’s market is positioned for stable growth driven by the expanding pharmaceutical and food sectors. While raw material volatility and regulatory challenges persist, technological innovation and strategic market expansion can propel profitability. Stakeholders should monitor commodity prices, regulatory developments, and emerging applications to optimize investment decisions and operational strategies.


Key Takeaways

  • The global sodium acetate market is projected to grow at approximately 4% CAGR until 2026, primarily fueled by pharmaceutical and food industry demand.
  • Pharmaceutical applications, particularly electrolyte and infusion solutions, constitute the largest revenue segment.
  • Raw material price fluctuations and environmental regulations present ongoing challenges but also opportunities for innovation and efficiency.
  • Emerging markets in Asia-Pacific represent significant growth prospects due to expanding healthcare infrastructure.
  • Strategic investments in environmentally sustainable manufacturing and product diversification can enhance competitive advantage.

FAQs

1. What are the primary pharmaceutical applications of sodium acetate?
Sodium acetate is mainly used as a buffering agent in intravenous fluids, electrolyte solutions, and dialysis fluids, helping maintain pH stability and electrolyte balance.

2. How does raw material price volatility affect the sodium acetate market?
Fluctuations in acetic acid prices, driven by oil and natural gas markets, directly influence sodium acetate manufacturing costs, impacting profit margins and pricing strategies.

3. Are there environmental concerns associated with sodium acetate production?
While generally considered environmentally safe, manufacturing processes must adhere to emissions regulations; investments in cleaner processes are increasingly necessary.

4. Which regions are expected to witness the fastest growth in sodium acetate demand?
Emerging economies in Asia-Pacific, notably China and India, are expected to experience the most rapid demand growth due to expanding healthcare and food sectors.

5. What future innovations could impact the sodium acetate market?
Advancements in green chemistry, biosynthesis, and alternative buffering agents could influence market dynamics, potentially leading to cost reductions and enhanced product safety.


Sources
[1] Allied Market Research, "Sodium Acetate Market by Application, Industry, and Region," 2022.
[2] Grand View Research, "Sodium Acetate Market Size & Trends," 2022.
[3] U.S. Food and Drug Administration, Regulatory Guidelines for Buffering Agents, 2022.
[4] European Food Safety Authority, "Evaluation of Food Additives," 2021.
[5] World Health Organization, "Pharmaceutical Excipients: Safety and Standards," 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.